Targeted Gynaecologic Oncology (TARGON)

University of Groningen > Faculty of Medical Sciences > Cancer Research Center Groningen (CRCG) > Targeted Gynaecologic Oncology (TARGON)

Contact information

  1. Galectin-9 Is a Possible Promoter of Immunopathology in Rheumatoid Arthritis by Activation of Peptidyl Arginine Deiminase 4 (PAD-4) in Granulocytes

    Wiersma, V. R., Clarke, A., Pouwels, S. D., Perry, E., Abdullah, T. M., Kelly, C., Soyza, A. D., Hutchinson, D., Eggleton, P. & Bremer, E., 19-Aug-2019, In : International Journal of Molecular Sciences. 20, 16

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis

    Malda, A., Boonstra, N., Barf, H., de Jong, S., Aleman, A., Addington, J., Pruessner, M., Nieman, D., de Haan, L., Morrison, A., Riecher-Roessler, A., Studerus, E., Ruhrmann, S., Schultze-Lutter, F., An, S. K., Koike, S., Kasai, K., Nelson, B., McGorry, P., Wood, S., Lin, A., Yung, A. Y., Kotlicka-Antczak, M., Armando, M., Vicari, S., Katsura, M., Matsumoto, K., Durston, S., Ziermans, T., Wunderink, L., Ising, H., van der Gaag, M., Fusar-Poli, P. & Pijnenborg, G. H. M., 21-May-2019, In : Frontiers in Psychiatry. 10, p. 345 17 p., 345.

    Research output: Contribution to journalReview articleAcademicpeer-review

  3. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    PORTEC study group, de Boer, S. M., Powell, M. E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P. B., Ledermann, J. A., Khaw, P., D'Amico, R., Fyles, A., Baron, M-H., Jürgenliemk-Schulz, I. M., Kitchener, H. C., Nijman, H. W., Wilson, G., Brooks, S., Gribaudo, S., Provencher, D., Hanzen, C., Kruitwagen, R. F., Smit, V. T. H. B. M., Singh, N., Do, V., Lissoni, A., Nout, R. A., Feeney, A., Verhoeven-Adema, K. W., Putter, H. & Creutzberg, C. L., 22-Jul-2019, In : Lancet Oncology. 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Hospital transfer after a breast cancer diagnosis: A population-based study in the Netherlands of the extent, predictive characteristics and its impact on time to treatment

    Nabon Breast Canc Audit, Apr-2019, In : EJSO. 45, 4, p. 560-566 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (1,485) »

  1. Data to: Evidence Based Selection of Housekeeping Genes

    de Jonge, H. (Creator), Fehrmann, R. (Creator), de Bont, E. (Creator), Hofstra, R. M. W. (Creator), Gerbens, F. (Creator), Kamps, W. (Creator), Vries, de, E. G. E. (Creator), Zee, van der, A. (Creator), te Meerman, G. (Creator), Elst, ter, A. (Creator), University of Groningen, 19-Sep-2007


  2. Dataset: Inter-laboratory agreement of the Cervista HPV HR test with a second cut-off at default setting of 1.93 (A) and at new setting of 5.0 (B)

    Boers, A. (Creator), Slagter-Menkema, L. (Creator), Hemel, van, B. (Creator), Belinson, J. L. (Creator), Ruitenbeek, T. (Creator), Buikema, H. J. (Creator), Klip, H. (Creator), Ghyssaert, H. (Creator), Zee, van der, A. (Creator), Bock, de, T. (Creator), Schuurs-Wisman, B. (Creator), Schuuring, E. (Creator), University of Groningen, 22-Jul-2014


View all (3) »

  1. Personal fellowship of the Dutch Cancer Society to study Palliative Medicine

    An Reyners (Recipient), 2005

    Prize: Fellowship awarded competitivelyAcademic

View all (2) »

  1. Heer van Haaften, arts van stand

    Hans Nijman (Speaker)

    Activity: Talk or presentationPopular

  2. De betekenis van regionale oncologienetwerken

    Hans Nijman (Speaker)

    Activity: Talk or presentationProfessional

  3. Wat hebben we gedaan aan regionalisatie van oncologische zorg

    Hans Nijman (Speaker)

    Activity: Talk or presentationProfessional

View all (91) »

Press / Media
  1. Macrofagen herprogrammeren voor effectievere immuuntherapie

    Toos Daemen


    1 item of media coverage

    Press/Media: Public Engagement ActivitiesPopular

  2. Kankervaccin klaar voor tests op patiënten

    Toos Daemen & Hans Nijman


    1 item of media coverage

    Press/Media: ResearchPopular

  3. ViciniVax

    Toos Daemen


    1 item of media coverage

    Press/Media: Public Engagement ActivitiesPopular

View all (3) »

View graph of relations

ID: 37379